Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

BackgroundThis study evaluates the risk of dermatologic adverse events (AEs) associated with aromatase inhibitors (AIs) through an analysis of data from the FDA Adverse Event Reporting System (FAERS).MethodsFAERS data from Q1 2004 to Q2 2024 were analyzed for dermatologic AEs related to AIs. A dispr...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuan-Yuan Wu, Qiong-Lian Huang, Zhan-Yang Luo, Xiao-Yun Song, You-Yang Shi, Jin-Zhou Zheng, Sheng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
aromatase inhibitors
dermatologic adverse events
FDA adverse event reporting system
disproportionality analysis
real-world
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1529342/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1529342/full

Similar Items